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Abstract
Subcapsular sinus macrophages (SSMs) in lymph nodes are rapidly exposed to antigens arriving in afferent lymph and have
a role in their capture and display to B cells. In tissue sections SSMs exhibit long cellular processes and express high
amounts of CD169. Here, we show that many of the cells present in lymph node cell suspensions that stain for CD169 are
not macrophages but lymphocytes that have acquired SSM-derived membrane blebs. The CD169 bleb
+ lymphocytes are
enriched for IL-17 committed IL-7Ra
hiCCR6
+ T cells and NK cells. In addition, the CD169 staining detected on small numbers
of CD11c
hi dendritic cells is frequently associated with membrane blebs. Counter intuitively the CD169 bleb
+ lymphocytes
are mostly CD4 and CD8 negative whereas many SSMs express CD4. In situ, many IL-7Ra
hi cells are present at the
subcapsular sinus and interfollicular regions and migrate in close association with CD169
+ macrophages. These findings
suggest SSMs undergo fragmentation during tissue preparation and release blebs that are acquired by closely associated
cells. They also suggest an intimate crosstalk between SSMs and IL-17 committed innate-like lymphocytes that may help
provide early protection of the lymph node against lymph-borne invaders.
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Introduction
Subcapsular sinus macrophages (SSMs) are a unique subset of
lymph node macrophages that form a dense layer overlapping
with the lymphatic lining that separates the lymphatic sinus and B
cell follicle. In situ staining has shown that SSMs express high
amounts of the sialic acid binding Ig-like lectin 1 (Siglec1 or
CD169) and the integrin CD11b (Mac1), and, in contrast to their
counterparts in the medulla, lack expression of the macrophage
marker F4/80 [1,2,3,4]. Many SSMs straddle the lymphatic lining
cells at the base of the subcapsular sinus, extending a ‘‘head’’ into
the sinus and long cellular processes (or ‘‘tails’’) into the adjacent B
cell follicle [1]. In contrast to the dynamic behavior of dendritic
cell processes [5,6,7], real time imaging studies have revealed that
the long cellular processes of SSMs are relatively static, potentially
indicating tight adhesion to adjacent stromal cells or extracellular
matrix [1,2,3,4].
Due to this unique localization, SSMs are poised to rapidly
encounter pathogens and antigens that reach the lymph node via
the lymph. Indeed, a number of studies have revealed that SSMs
have the capacity to capture a range of antigens, including viral
particles, immune complexes, antigen-loaded beads, and other
opsonized antigens [8]. In contrast to classical macrophages,
which typically internalize and degrade antigen, SSMs are thought
to be poorly phagocytic [9,10], a property that may contribute to
their capacity to function as antigen-presenting cells for B cells.
Antigen captured by SSMs is displayed on macrophage ‘‘tails’’
that extend into the B cell follicle, where B cells can directly
acquire antigen via complement or B cell receptors [1,2,3,4].
SSMs have also been shown to activate iNKT cells. Subcutane-
ously injected a-GalCer-coated microspheres were captured by
SSMs, processed, and presented via CD1d to iNKT cells [11]. In
addition to these antigen presentation functions, a number of
recent studies have shown that SSMs are an early site of
replication for a number of viruses [12–13] as well as the parasite
Toxoplasma gondii [14]. SSMs have been suggested to be unusually
permissive for pathogen infection, a property that might foster
local production of cytokines that protect other cell types from
infection [15].
As part of a continued effort to understand the biology of SSMs,
attempts to isolate and study these CD169
hi cells have been made
by us [2] and others [3,15,16,17,18]. Here we report that many of
the cells in lymph node cell suspensions that stain for CD169 are
lymphocytes that have acquired SSM-derived membrane blebs
and thus masquerade as CD169
hi SSMs during flow cytometric
analysis. This acquisition does not appear to be a random process
as CD169 bleb
+ lymphocytes are enriched for IL-17 committed
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hiCCR6
+ T cells and NK cells. Moreover, in situ and real-
time imaging analysis reveals that IL-7Ra
hi CXCR6
hi cells are
present at the subcapsular sinus and in interfollicular regions, often
migrating over the membrane processes of CD169
+ macrophages.
These observations raise the possibility of crosstalk between SSMs
and innate-like lymphocyte populations that may have important
roles in the early phases of lymph node immune responses.
Results
Detection of CD169
+ staining on IL-7Ra
hiCCR6
+
lymphocytes
In situ staining has revealed that SSMs are
CD169
hiCD11b
+CD11c
lo cells that, in contrast to the medullary
macrophages, are F4/80
2 [1,2,3,4]. Previously, we identified a
population of CD169
hiCD11b
+CD11c
loF4/80
2 cells by flow
cytometry that appeared to correspond to SSMs [2]. In further
efforts to characterize CD169
hiCD11c
lo cells by flow cytometry,
we observed that many of the cells with a CD169
hiCD11c
lo
phenotype also expressed IL-7Ra (Figure 1A). However, subse-
quent analysis of IL-7Ra expression in tissue sections revealed that
SSMs were IL-7Ra
2. Instead, we observed a population of IL-
7Ra
hi cells, with a rounded, lymphocyte-like morphology, which
were present at the subcapsular sinus and interfollicular regions of
the lymph node ([19] and Figure 1B and Supplemental Figure S1).
These cells expressed higher amounts of IL-7Ra than the bulk
population of T zone T cells and were often closely associated with
the macrophages (Figure 1B). In some cases, CD169
+ SSM
‘‘arms’’ appeared to be wrapped tightly around the IL-7Ra
hi cells
(Figure 1B, far right bottom panel), although the resolution of the
imaging analysis could not exclude the possibility that some IL-
7Ra
hi cells were expressing CD169.
These results suggested that IL-7Ra
hi lymphocytes that stained
positively for CD169 in flow cytometric analysis might have been
contaminating the SSM gate. Further analysis of the IL-
7Ra
hiCD169
hiCD11c
lo cells by flow cytometry revealed that the
majority were CCR6
+ (Figure 1C). When we gated on IL-
7Ra
hiCCR6
+ cells from total lymph node cells, we observed that
this gate included both CD3e
+ T lymphocytes and CD3e
2 non-T
cells. Moreover, there was a ‘‘smear’’ of CD169 staining spanning
almost a 2-log range on a fraction of both the IL-7Ra
hiCCR6
+
CD3e
+ T lymphocytes and CD3e
2 non-T cells (Figure 1D, top
panels). CD3e
+IL-7Ra
hiCCR6
+ cells were absent in a TCRbd-
deficient mouse, confirming that a subset of the IL-7Ra
hiCCR6
+
cells were T lymphocytes (Figure 1D).
To exclude the possibility that the CD169 antibody Ser4 was
cross-reacting with a non-CD169 epitope on IL-7Ra
hiCCR6
+
cells, we stained lymph node cell suspensions with 3D6, an
antibody that recognizes a distinct epitope on CD169 [20]. IL-
7Ra
hiCCR6
+ lymphocytes that bound Ser4 also stained with 3D6
(Figure 2A), suggesting that CD169 was present on the lympho-
cytes. As a further test that these cells were specifically staining for
CD169, we utilized CD169-DTR mice, in which the diptheria
toxin receptor (DTR) is knocked into the Siglec1 locus. Intraper-
itoneal administration of diphtheria toxin (DT) causes ablation of
CD169-expressing cells, including the SSMs in these mice [16,21].
Following DT treatment, there was a loss of CD169
+ cells by flow
cytometry, including CCR6
+CD169
+ cells (Figure 2B), indicating
that CD169 staining on IL-7Ra
hiCCR6
+ lymphocytes is specific.
However, when we measured CD169 transcripts on sorted
CD169
+ and CD169
2 IL-7Ra
hiCCR6
+ lymphocytes, we detected
low levels of Siglec1 mRNA in both the CD169
+ and CD169
2
fraction (Figure 2C). In contrast, Siglec1 mRNA was abundant in
sorted CD169
+CD11c
loF4/80
+ cells (i.e. cells that stain positive for
medullary sinus macrophage markers) (Figure 2C). These data do
not exclude the possibility that IL-7Ra
hiCCR6
+ cells do intrinsi-
cally express low levels of Siglec1 mRNA. However given the low
abundance of mRNA detected in both CD169
+ and CD169
2 IL-
7Ra
hiCCR6
+ lymphocytes, despite more than a 10-fold difference
in CD169 staining by flow cytometry, we wondered whether these
cells were acquiring CD169 in trans from other cells.
IL-7Ra
hiCCR6
+ lymphocytes acquire CD169
+ SSM-derived
membrane blebs
To test whether IL-7Ra
hiCCR6
+ cells were acquiring CD169 in
trans from other cells, we analyzed chimeras in which irradiated
Siglec1
+/+ (CD169-sufficient) mice were reconstituted with con-
genically-distinct Siglec1
2/2 (CD169-deficient) bone marrow.
Analysis of tissue sections established that the majority of CD169
hi
SSMs were replaced by donor-derived Siglec1
2/2 cells in these
animals; however, a small fraction of radiation-resistant CD169
+
macrophages remained (Figure 2D), consistent with earlier
findings [2]. We also found that a fraction of the IL-7Ra
hiCCR6
+
lymphocytes were radiation resistant such that about 1/3 of the
cells with this phenotype in the chimeras were host-derived
CD45.2
+ cells (not shown). Analysis of CD169 expression by IL-
7Ra
hiCCR6
+ lymphocytes isolated from the chimeric mice
revealed reduced CD169 staining compared to IL-7Ra
hiCCR6
+
lymphocytes from non-chimeric Siglec1
+/+ mice (Figure 2E).
However, CD169 staining was similar on CD45.2
+ Siglec1
2/2
donor BM-derived IL-7Ra
hiCCR6
+ lymphocytes and CD45.1
+
Siglec1
+/+ radiation-resistant host cells (Figure 2E). Since the
Siglec1
2/2 cells cannot express CD169 endogenously, they must
have acquired the CD169 in trans, most likely from the few wild-
type SSMs remaining in these chimeric mice. Analysis of mixed
bone marrow chimeras that were reconstituted with ,5%
CD45.2
+ Siglec1
2/2 cells and ,95% CD45.1
+ Siglec1
+/+ cells also
revealed no difference in CD169 staining on Siglec1
2/2 and
Siglec1
+/+ IL-7Ra
hiCCR6
+ cells (Supplemental Figure S2A),
confirming that these lymphocytes were acquiring CD169 in trans.
These combined data led us to hypothesize that IL-7Ra
hi
CCR6
+ lymphocytes acquire CD169
+ macrophage-derived mem-
brane fragments or ‘‘blebs’’. Consistent with this possibility, we
observed that CD169 staining intensity on IL-7Ra
hi lymphocytes
correlated with other markers expressed by SSMs based on in situ
staining, such as CD11b (Figure 2F). To explore the possibility that
these cells acquire CD169
+ blebs, CD169
+ IL-7Ra
hiCCR6
+
lymphocytes were sorted and fixed to slides to visualize CD169
staining. CD169-staining membrane blebs were observed attached
to the surface of IL-7Ra
hiCCR6
+ lymphocytes (Figure 2G).
Consistent with the range in CD169 staining intensity observed
by FACS, we noted significant variation in the number and size of
blebs attached to each cell. In some cases the amount of CD169
surface staining was extensive. However, even in many of these
cases, the marker did not appear uniformly distributed across the
plasma membrane, suggesting that the staining was associated with
a macrophage-derived membrane process that encompassed a
large part of the lymphocyte surface (Figure 2G, far right panel).
To assess CD169
+ bleb acquisition by IL-7Ra
hiCCR6
+
lymphocytes more quantitatively, experiments were carried out
using ImageStreamX imaging flow cytometry (Amnis Corp). Cells
with the CD169
+ IL-7Ra
hiCCR6
+ marker profile were gated and
CD169 surface distribution was analyzed. Similar to our
observations with sorted cells, we observed CD169
+ ‘‘blebs’’ of
various sizes on the surface of the cells (Figure 3A, B). To quantify
the fraction of cells with small compared to large CD169
+ ‘‘blebs’’,
we calculated the area of CD169 staining on the gated cells and
separated the images into small, medium, and large area gates
IL-17-Committed Lymphocytes Acquire CD169
+ Blebs
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+ IL-7Ra
hiCCR6
+ cells had a small
area of CD169 staining, while approximately 15% had a large
area of staining (Figure 3B). CD169
+ IL-7Ra
hiCCR6
+ cells in the
small area gate (R11) tended to have small, punctate CD169
staining, while those in the large area gate (R13) tended to have
CD169 staining covering the majority of the cell (Figure 3B).
Whether these rare cells with a large area of CD169 staining have
acquired very large CD169
+ blebs or actually express CD169 will
require future study.
High CD169 staining was recently reported on a subset of
CD11c
hi tumor-antigen-presenting lymph node cells [16]. Given
the above findings, we wondered whether CD169
hiCD11c
hi cells
all express CD169, or whether some might be CD11c
hi dendritic
cells that have acquired CD169
+ blebs. Consistent with the latter
possibility, analysis of mixed bone marrow chimeras revealed no
difference in CD169 staining on Siglec1
2/2 and Siglec1
+/+ CD11c
hi
cells (Supplemental Figure S2B). Thus, like IL-7Ra
hiCCR6
+
Figure 1. Detection of CD169
+ IL-7Ra
hiCCR6
+ lymphocytes in digested lymph node tissue. (A) Flow cytometric detection of IL-7Ra
expression on CD169
+CD11c
lo cells from digested lymph nodes. (B) Immunofluorescence microscopy of a lymph node section stained with anti-
CD169 and anti-IL-7Ra monoclonal antibodies. Enlargements (bottom, far right) show examples of IL-7Ra
+ cells (white arrows) closely associated with
CD169
+ SSMs. FO, follicle; T, T zone. (C) Flow cytometric analysis showing CD169
+CD11c
lo cells contain a population of IL-7Ra
hiCCR6
+ cells. All data in
A–C are representative of at least three independent experiments. (D) Flow cytometric analysis of digested lymph node cells from a control and
TCRbd-deficient mouse. IL-7Ra
hiCCR6
+ cells gated from total cells express CD169 on a fraction of both CD3e
+ and CD3e
2 cells. Data are representative
of at least three independent experiments (control mice) and one experiment in which a TCRbd-deficient mouse was analyzed.
doi:10.1371/journal.pone.0038258.g001
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hi cells can acquire CD169 in trans. We then
asked whether we could visualize CD169
+ blebs on CD11c
hi cells
using imaging flow cytometry. Indeed, analysis of gated
CD169
+CD11c
+ cells showed bleb-like CD169 staining on many
of these cells (Figure 3D). Quantification of the CD169 staining
area revealed that the majority of CD169
+CD11c
hi cells had a
small area of CD169 staining, corresponding to CD11c
hi cells with
small blebs of CD169 staining (Figure 3C, D). Less than 15% of
CD169
+CD11c
hi cells had a large area of CD169 staining, which
sometimes appeared uniform and covered much of the cell
(Figure 3C, D). These cells may correspond to rare CD11c
hi cells
that express CD169 or that have acquired large CD169
+ blebs.
Together, these data suggest that the majority of CD169
+CD11c
hi
cells are dendritic cells that have acquired CD169+ blebs.
CD169 bleb
+ cells are enriched for IL-7Ra
hiCCR6
+ cells
and NK cells
These results suggested that IL-7Ra
hiCCR6
+ cells do not
express CD169, but rather that they acquire CD169
+ macro-
phage-derived blebs. Bleb acquisition does not appear to be a
random process, as CD169
+ staining was enriched on IL-
7Ra
hiCCR6
+ lymphocytes compared to total T and B cells
(Figure 4A). Furthermore, we observed enrichment for CD169
staining on NK1.1
+DX5
+CD3e
2 NK cells, suggesting that NK
cells also acquire blebs from CD169
hi macrophages (Figure 4A).
This may suggest that these cell types have a unique capacity to
capture blebs that are shed by the SSMs either in vivo or during
tissue preparation. Alternatively, given that IL-7Ra
hi cells are
located near CD169
+ SSMs in situ (Figure 1B and Supplemental
Figure S1), bleb acquisition may be dependent on localization
Figure 2. IL-7Ra
hiCCR6
+ lymphocytes acquire CD169
+ SSM-derived membrane blebs. (A) Flow cytometric detection of CD169 on digested
lymph node cells stained with two anti-CD169 monoclonal antibodies, Ser4 and 3D6. The top panel is pre-gated on IL-7Ra
hiCCR6
+ cells; the bottom
panel shows total cells. Data are representative of three independent experiments. (B) Expression of CD169 on total cells from digested lymph nodes
from CD169-DTR mice treated with saline or DT 3 or 4 days prior to analysis. Data are representative of two independent experiments. (C) Siglec1
mRNA quantification by RT-PCR in sorted CD169
+ and CD169
– IL-7Ra
hiCCR6
+ cells, CD169
+CD11c
loF4/80
– cells, and CD169
+CD11c
loF4/80
+ cells. Data
are plotted relative to HPRT. (D) Immunofluorescence microscopy of lymph nodes stained with anti-CD169 and anti-CD11b monoclonal antibodies
from a Siglec1
–/– bone marrow chimeric mouse (top panel) or control non-chimeric mouse (bottom). Scale bar=50 mm. Data are representative of one
experiment. (E) Flow cytometric detection of CD169 staining on CD45.1
+ Siglec1
+/+ radiation-resistant (blue) compared to donor bone-marrow-
derived CD45.2
+ Siglec1
–/– (red) IL-7Ra
hiCCR6
+ cells. CD169
+ staining on IL-7Ra
hiCCR6
+ cells from a non-chimeric control animal are represented in
black. Data are representative of two experiments. (F) Flow cytometric detection of CD169 and CD11b on IL-7Ra
hiCCR6
+ cells from digested lymph
nodes. Data are representative of two experiments. (G) CD169
+IL-7Ra
hiCCR6
+B220
2 cells from digested lymph nodes were sorted and fixed to a slide
for immunofluorescence microscopy. Data are representative of one experiment.
doi:10.1371/journal.pone.0038258.g002
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hiCCR6
+ lymphocytes and CD11c
hi dendritic cells using ImageStreamX imaging
flow cytometry. (A) Gating scheme to identify CD169
+IL-7Ra
hiCCR6
+ cells analyzed on an ImageStreamX imaging flow cytometer (Amnis Corp). The
area of CD169 staining on images of the gated cells was quantified using a Threshold mask on the upper 60% of the pixel intensities (right panel). (B)
Representative images of cells with small, medium, and large areas of CD169 area based on the histogram in (A). Channels for CD169 (green), IL-17Ra
(red), and brightfield are shown. Graph on right shows the frequency of cells falling in each gate (n=2 mice, lines indicate means). (C) Gating scheme
to identify CD169
+CD11c
+ cells analyzed on an ImageStreamX imaging flow cytometer. The area of CD169 staining on images of the gated cells was
quantified as described in (A). (D) Representative images of cells with small, medium, and large areas of CD169 area based on the histogram in (C).
Channels for CD169 (green) IL-17Ra (red), and brightfield are shown. Graph on right shows the frequency of cells falling in each gate (n=2 mice, lines
indicate means). Data are representative of one experiment with two mice. In a second experiment with two mice, CD169
+ blebs were visualized on
CD169
+CCR6
+TCRcd
+ cells.
doi:10.1371/journal.pone.0038258.g003
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CD169
+ bleb acquisition as the fraction of IL-7Ra
hiCCR6
+
lymphocytes that were CD169
+ by flow cytometry was similar in
digested compared to undigested cell suspensions (Figure 4B). The
total number of IL-7Ra
hiCCR6
+ lymphocytes was greater in
digested samples, suggesting that while digestion improved the
recovery of these lymphocytes, it was not required for bleb
acquisition per se.
IL-7Ra
hiCCR6
+ lymphocytes are IL-17 committed cells
that interact with CD169
+ macrophages
IL-7Ra
hiCCR6
+ cells express high levels of CXCR6 ([19] and
Figure 5A), a chemokine receptor enriched on effector and
memory T cells [22]. Consistent with an effector phenotype, flow
cytometric analysis revealed that IL-7Ra
hiCCR6
+ cells were
CD44
hi and CD62L
lo (Figure 5A). Based on their expression of
CCR6, a marker of IL-17 committed cells [23], we hypothesized
that these cells were programmed to make IL-17A. Indeed, the IL-
7Ra
hiCCR6
+ lymphocytes rapidly produced IL-17A following
phorbol ester plus ionomycin stimulation ex vivo, although there
was no difference in the capacity of CD169 bleb
+ cells to make IL-
17A compared to the bleb
2 fraction (Figure 5B). The ability of the
IL-7Ra
hiCCR6
+ lymphocytes to rapidly produce cytokines ex vivo
in addition to their effector phenotype suggested that these cells
correspond to the IL-17A committed cells recently described by
several groups [24].
The IL-7Ra
hiCCR6
+ gate included cdT, abT, and non-T cells
(Figure 5C) all of which showed a smear of CD169 staining. The
IL-7Ra
hiCCR6
+ cdT cells correspond to innate IL-17 producing
cdT that have been described in the dermis and peripheral lymph
nodes [19,25,26]. We observed that approximately 15–20% of IL-
7Ra
hiCCR6
+ cells were CD1d-tetramer
+ CD3e
int iNKT cells,
which showed a smear of CD169 staining (Figure 5D). These
CCR6
+ iNKT cells likely correspond to the IL-17 producing
iNKT cells recently described in skin and peripheral lymph nodes
[27].
Analysis of CD4 expression by the IL-7Ra
hiCCR6
+ T cells
showed a smear of CD4 signal, much of which correlated with
CD169 staining (Figure 5E, top panel, upper quadrants) as well as
a population of T cells with a conventional CD4
hiCD169
2
phenotype (Figure 5E, top panel, lower right quadrant). In
contrast, the IL-7Ra
hiCCR6
+ T cells were CD8
2 (Figure 5E,
bottom panel). The smear of CD4 staining suggested, counter
intuitively, that the SSMs express CD4 and that the CD4
2 IL-
7Ra
hiCCR6
+ T cells were acquiring CD4
+CD169
+ blebs from the
macrophages. Indeed, analysis of CD4 expression in situ revealed
CD4 staining on the majority of CD169
+ SSMs in control but not
CD4-deficient mice (Figure 5F).
Finally, we took advantage of the high expression of CXCR6 by
IL-7Ra
hiCCR6
+ cells to gain a more precise assessment of their
localization in lymph node tissue sections than can be achieved by
IL-7Ra-staining alone. Approximately 60–80% of IL-7Ra
hi
CXCR6
hi lymphocytes identified by flow cytometry are CCR6
+
[19] (and data not shown), suggesting that the majority of IL-
7Ra
hiCXCR6
hi cells on sections correspond to IL-7Ra
hiCCR6
+
IL-17-committed lymphocytes. Using Cxcr6
GFP/+ reporter mice
[22], we found that the IL-7Ra
hiCXCR6
hi cells were abundant in
subcapsular and interfollicular regions, often adjacent to CD169
+
macrophages (Supplementary Figure S3). Moreover, two photon
laser scanning microscopy of intact lymph nodes revealed
CXCR6
hi (GFP
hi) cells migrating in close association with
CD169+ macrophages in subcapsular sinus and interfollicular
regions (Supplementary Movies S1 and S2).
Discussion
We report here that many of the cells in lymph node cell
suspensions that stain positively for SSM-markers are not
macrophages, but rather IL-7Ra
hiCCR6
+ lymphocytes and NK
cells that have acquired CD169
+ SSM-derived membrane blebs.
Figure 4. CD169 bleb
+ cells are enriched for IL-7Ra
hiCCR6
+ cells
and NK cells. (A) Flow cytometric detection of CD169 on digested
lymph node cells gated on IL-7Ra
hiCCR6
+ cells, NK1.1
+DX5
+CD3e
2 cells,
CD3e
+ cells, and B220
+ cells. (B) Flow cytometric detection of CD169 on
IL-7Ra
hiCCR6
+ cells from digested (top panel) or non-digested (bottom
panel) lymph nodes. All data are representative of at least two
independent experiments.
doi:10.1371/journal.pone.0038258.g004
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38258This conclusion is established by: (i) the incomplete concordance
between surface marker expression on CD169
+ cells detected in
tissue sections and by flow cytometry; (ii) the low abundance of
CD169 transcripts in CD169
+ IL-7Ra
hiCCR6
+ cells by quantita-
tive PCR as well as in microarray analysis of FACS sorted CD169
+
CD11b
+CD11c
loF4/80
2 cells [2,28]; (iii) the positive CD169
staining on Siglec1
2/2 IL-7Ra
hiCCR6
+ cells in Siglec1
+/+ hosts,
and; (iv) the visualization of CD169
+ blebs on the surface of sorted
cells and cells examined using ImageStreamX flow cytometry. The
tendency of IL-7Ra
hiCCR6
+ lymph node cells to acquire CD169
+
macrophage-derived blebs suggests there may be a propensity for
these two cell types to interact in vivo. Future studies should
explore whether a specific interaction between IL-7Ra
hiCCR6
+
lymphocytes and CD169
+ macrophages occurs in vivo, and, if so,
define the functional consequences.
An important question that arises from these observations is
whether bleb acquisition by IL-7Ra
hiCCR6
+ lymphocytes occurs
in vivo or during cell preparation. Arguing against acquisition
being a prominent process in vivo, during real-time imaging
studies of intact lymph nodes in mice intravitally labeled with
CD169 antibodies, we have so far not observed CD169 marker
acquisition by migrating lymphocytes (Supplementary Movies S1
and S2, and data not shown). Therefore, we favor the view that
bleb acquisition predominantly occurs during tissue preparation.
The finding that CD169 acquisition by IL-7Ra
hiCCR6
+ cells was
similar whether the lymph nodes were gently teased apart and
enzyme digested or simply mechanically separated suggests that
Figure 5. IL-7Ra
hiCCR6
+ lymphocytes are IL-17 producing cells. (A) CD44, CD62L and CXCR6 expression on digested lymph node cells from
control or Cxcr6
GFP/+ mice, gated on IL-7Ra
hiCCR6
+ cells. (B) IL-17A staining of digested lymph node cells, stimulated with PMA/I for 2 h, gated on
gated on IL-7Ra
hiCCR6
+ cells. (C) abT and cdT staining on digested lymph node cells, gated on IL-7Ra
hiCCR6
+ cells; CD169 staining of abT
+, cdT
+ and
TCR
2 IL-7Ra
hiCCR6
+ cells gated as indicated in the left panel. (D) Flow cytometric detection of IL-7Ra
hiCCR6
+ cells that bind CD1d-tetramers; far right
panel shows CD169 staining on CD1d-tetramer
+ IL-7Ra
hiCCR6
+ cells. (E) CD169, CD4, and CD8 staining on digested lymph node cells, gated on IL-
7Ra
hiCCR6
+ cells. (F) Immunofluorescence microscopy of a lymph node from a wild-type or a CD4-deficient mouse, stained with anti-CD169 and anti-
CD4 monoclonal antibodies. FO, follicle; T, T zone. Scale bar=50 mm. All data are representative of at least two independent experiments.
doi:10.1371/journal.pone.0038258.g005
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38258SSMs may be highly prone to fragmentation, perhaps due to
strong attachments to the surrounding cells or extracellular matrix.
Alternatively, the cells may be programmed to undergoing
blebbing during apoptosis. In this regard it is notable that dying
germinal center B cells in intact lymph nodes can release blebs that
are acquired by neighboring lymphocytes [29] and active ROCK-
dependent membrane blebbing during apoptosis has been
reported in a number of in vitro studies [30]. In addition, one
physiological mechanism of axon pruning involves active mem-
brane blebbing [31]. Whatever the mechanism for the SSM
blebbing, the present findings highlight the challenges associated
with isolating pure populations of SSMs, challenges that likely
extend to other cell populations with long membrane processes,
such as the closely related CD169
+ marginal metallophillic
macrophages (MMMs) in the spleen and the non-hematopoietic
follicular dendritic cells in all secondary lymphoid tissues. MMM
isolation and analysis by flow cytometry has been reported in a
number of studies but few of these studies have examined the
isolated cells by microscopy. In a report where the low density
(macrophage-enriched) fraction of cells from digested spleen and
lymph nodes was examined by microscopy, less than 0.1% of the
cells stained for markers corresponding to MMM and SSM; these
cells were noted to have a granular cytoplasm and in some cases
appeared tightly associated with lymphocyte-sized cells [32].
Given that CD169 bleb
+ cells are enriched for IL-7Ra
hiCCR6
+
cells and NK cells, in future efforts to isolate SSMs it will be
important to include IL-7Ra, CCR6, and NK1.1 in addition to
CD3e and B220 in a lineage ‘dump’ gate, while keeping in mind
that SSMs are CD4
+. In our initial efforts to perform such an
analysis we have found that there are very few lineage ‘dump’
negative cells (unpubl. obs.). However, it must also be considered
likely that SSMs themselves will be strongly associated with IL-
7Ra
hiCCR6
+ cells, causing them to be lost during doublet or
‘dump’ gating. In future studies, it will be important to perform
microscopy on CD169
hi cells of large size, including cells that
might be classified as doublets on flow cytometry, to more
definitively test for the amount of SSM recovery that can be
achieved with current tissue digestion procedures. Macrophage
reporter mice, such as the MacGreen mice [33] or Lysozyme M-
cre [34] x Rosa-stop
floxYFP mice may be of utility in identifying
intact SSMs, given that the cytoplasmic reporter molecules may be
restricted to intact macrophages and absent from macrophage-
derived blebs. Until improved isolation and cell tracing procedures
are developed it will be important to confirm any unique
properties of the cells suggested based on gene expression analysis
of sorted cells [2,15,17] through assessments of gene or protein
expression by the cells in situ or after isolation from snap-frozen
tissue by laser capture microscopy [35].
Our finding that mouse SSMs express CD4 is consistent with an
earlier study in rats showing CD4 expression by these cells [36].
Most other mouse macrophage populations, including peritoneal
macrophages, Kupffer cells, and red pulp macrophages do not
express CD4, in contrast to rats as well as humans, in which CD4
expression by monocytes and macrophages is more widespread
[37]. Thus, CD4 expression may be a special feature of these
lymph node macrophages. CD4 expression by human lymph node
sinus macrophages, which may correspond to mouse subcapsular
sinus macrophages, has been reported [38]. SSMs are thought to
be uniquely permissive for viral replication [12,15,35] raising the
possibility that expression of the HIV-coreceptor CD4 by SSMs
may play an important role during HIV infection and perhaps also
in the capture and display of HIV-1 virions for recognition by B
cells.
We describe a population of IL-7Ra
hiCCR6
+CXCR6
hi lym-
phocytes that are abundant at the subcapsular sinus and in
interfollicular regions. This is a diverse population of cells,
including cdT, abT, and non-T cells, all of which rapidly produce
IL-17A when stimulated with PMA and ionomycin ex vivo. The
IL-7Ra
hiCCR6
+ TCRcd
+ cells correspond to innate IL-17
producing cdT that have been described in the dermis and
peripheral lymph nodes [19,25,26]. 15–20% of IL-7Ra
hiCCR6
+
cells were iNKT cells, which likely correspond to the IL-17
producing iNKT cells recently described in skin and peripheral
lymph nodes [27]. In another study, approximately 10% of
adoptively transferred iNKT cells localized to the interfollicular or
subcapsular sinus regions of the lymph node [17], consistent with
the notion that at least a subset of iNKT localize near SSMs in the
steady state. What types of effector cells the remaining TCRb
+
CD4 and CD8 double negative cells and CD3e
2 cells in the
CD169
+IL-7Ra
hiCCR6
+ gate correspond to is unclear, although
they may include IL-17 producing LTi-like cells [24,39].
The presence of IL-17 committed lymphocytes in or near the
subcapsular sinus and their migration in close association with
CD169
+ macrophages raises the possibility that these cell types
functionally interact. The spontaneous clustering or ‘swarming’ of
CXCR6
hi (GFP
hi) cells in close proximity with SSMs observed in
some of our imaging experiments (Supplementary Movie S2) also
provides support for crosstalk between these cells though the
type(s) of stimuli that provoke this behavior are not yet defined. IL-
17 plays an important role in immunity at barrier surfaces, such as
the skin [24]. One might consider the subcapsular sinus lining cells
as a second barrier, given the dense network of macrophages and
size-exclusion properties of this site as well as the constant
exposure to lymph fluid that delivers antigens to the sinus within
seconds to minutes of inoculation [1,3,40,41]. CD169
+ macro-
phages, including cells at the subcapsular sinus and in interfollic-
ular regions, constantly sample the lymph draining the skin for
antigen and likely also for inflammatory cytokines. Thus, one
intriguing possibility is that SSMs sense lymph-derived signals and
activate adjacent lymphocytes by producing IL-17-promoting
cytokines, such as IL-1b and IL-23 [42,43] or upregulating
presentation of their cognate ligands, such as the recently
described endogenous iNKT ligand, b-GlcCer [44]. Early
production of IL-17 and possibly additional cytokines may
enhance pro-inflammatory cytokine production and microbicidal
activity of the macrophages [45,46] and help maintain the barrier
function of the subcapsular sinus while influencing the initial
induction of effector T [42] and B cells [47] within the lymph node
parenchyma. Future studies should explore whether crosstalk
between IL-17 committed lymphocytes and SSMs plays a role in
protecting the lymph node from invading pathogens and in
guiding early phases of lymph node immune responses.
Materials and Methods
Ethics Statement
All experiments conformed to ethical principles and guidelines
approved by the UCSF Institutional Animal Care and Use
Committee under protocol authorization number AN087331-01.
Mice
C57BL/6 (CD45.2
+), Boy/J (CD45.1
+), Cxcr6
gfp/+ ([22];
005693, B6.129P2-Cxcr6
tm1Litt/J), TCRbd
2/2 ([48]; 002122,
B6.129P2-Tcrb
tm1MomTcrd
tm1Mom/J), and CFP-transgenic ([49];
004218; B6.129(ICR)-Tg(CAG-ECFP)CK6Nagy/J) mice were
from The Jackson Laboratory (Jax), Taconic, or National Cancer
Institute. Siglec1
2/2 (CD169-deficient) mice [50] were kindly
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DTR/+ (CD169-DTR) mice
[21] were kindly provided by Dr. Masato Tanaka; Cd4
2/2 (CD4-
deficient) mice [51] on a FvB/N background and FvB/N control
mice were kindly provided by Dr. Lisa Coussens.
Tissue preparation
Unless otherwise indicated, lymph nodes were digested as
described [2]. Briefly, lymph nodes were teased apart in DMEM
containing penicillin/streptomycin and HEPES buffer and digest-
ed with 67 mg/ml Liberase TM (Roche) and 20 mg/ml DNAse I
(Sigma) for 20 minutes while rotating. The digestion was then
quenched by the addition of 10% fetal bovine serum (FBS) and
5 mM EDTA and lymph nodes were disaggregated by mashing
through 100 mm nylon sieve (BD Bioscience).
Flow cytometry
Cells were stained [2] in ‘‘FACS buffer’’ (PBS with 0.1% sodium
azide, 2% FBS, and 1 mM EDTA) with antibodies to TCRcd
(GL3), TCRb (H57-597), IL-17A (eBio17B7), CD196/CCR6
(140706), IL-7Ra (A7R34 or B12-1), CD3e (clone 145-2C11),
CD11c (clone HL3 or N418), CD11b (clone Mac-1), CD4 (clone
GK1.5), CD8 (clone 53-6.7), NK1.1 (clone PK136), CD49b (clone
DX5), CD44 (clone IM7), CD62L (clone MEL-14), F4/80 (clone
Cl:A3-1), CD45.2 (clone 104) and CD45.1 (clone A20) (Biolegend,
BD Biosciences, eBioscience, Cedarlane Laboratories, or Invitro-
gen). Biotin-conjugates were detected with streptavidin QdotH 605
(Invitrogen). PBS-57-loaded CD1d tetramers were provided by the
National Institutes of Health tetramer core facility (PBS-57 is an
analogue of a-galactosylceramide). Anti-CD169 (clone Ser4) was
kindly provided by Dr. Paul Crocker; Molecular ProbesH
Monoclonal Antibody Labeling Kits (Invitrogen) were used to
directly conjugate Ser4 antibody to AlexaFluor488, Alexa-
Fluor647, or Pacific Blue dyes. FITC-conjugated anti-CD169
([52] clone 3D6.122) was purchased from AbD Serotec. Unless
otherwise indicated, the Ser4 antibody was used to detect CD169.
During analysis, singlets were gated based on peak FSC-H/FSC-
W and SSC-H/SSC-W. These gates encompassed more than 90%
of total events and were set sufficiently widely to include singlet
events of variable size while avoiding the main doublet peak.
To detect IL-17A, cells were stimulated for 2 h with 50 ng/ml
PMA (Sigma) and 1 mg/ml Ionomycin (I, EMD Biosciences) in
Brefeldin A (BD Biosciences), stained for surface antigens, treated
with BD Cytofix Buffer and Perm/Wash reagent (BD Biosciences),
and stained with anti-IL-17A.
Cell sorting
Digested lymph node cells were blocked with anti-CD16/32
(clone 2.4G2, UCSF hybridoma core) in 5% normal mouse serum
and 5% normal rat serum in DMEM/2% FBS/5 mM EDTA and
stained with anti-CD169-AlexaFluor488, anti-IL-7Ra-PE, anti-
CCR6- AlexaFluor647, and anti-B220-biotin. The B220-biotin
conjugate was detected with streptavidin QdotH 605 (Invitrogen).
Dead cells were excluded with DAPI and CD169
+IL-7Ra
hi
CCR6
+B220
2 and CD169
2IL-7Ra
hiCCR6
+B220
2 subsets were
sorted on a FACSAria with a purity of at least 88%.
CD169
+CD11c
loF4/80
+ and CD169
+CD11c
loF4/80
– cells were
sorted as described [2].
RNA was extracted and Siglec1 mRNA was quantified as
previously described [2]. For imaging, a fraction of sorted cells
were washed with PBS containing 0.1% BSA and 0.1% sodium
azide and applied to a chambered coverslip (CultureWell,
Molecular Probes). After allowing cells to settle for 20 minutes at
room temperature, supernatent was carefully aspirated from the
coverslips. The cells were then fixed to the coverslip for
10 minutes at room temperature with 40 ml of 4% paraformalde-
hyde. Coverslips were washed with PBS, stained with DAPI, and
then mounted onto a glass slide. Images were acquired with a Zeiss
AxioObserver Z1 inverted microscope using equivalent exposure
times. Optimal exposure times were determine based on the
CD169 staining intensity of the majority of the sorted cells.
Amnis ImageStreamX imaging flow cytometry
Digested lymph node cells were blocked with anti-CD16/32
(clone 2.4G2, UCSF hybridoma core) in 5% normal mouse serum
and 5% normal rat serum in ‘‘FACS buffer’’ (PBS with 0.1%
sodium azide, 2% FBS, and 1 mM EDTA) and stained with anti-
CD11c-FITC, anti-IL-7Ra-PE, anti-CCR6-AlexaFluor647, anti-
CD169-Pacific Blue and anti-F4/80-biotin. The F4/80-biotin
conjugate was detected with streptavidin QdotH 605 (Invitrogen).
After washing, cells were fixed for 30 minutes on ice with BD
Cytofix Buffer, resuspended in FACS buffer, and analyzed on an
Amnis ImageStreamX imaging flow cytometer instrument. In a
second experiment cells were stained with anti-CD169-Alexa-
Fluor488, anti-TCRcd-PE, anti-CCR6-AlexaFluor647, and anti-
TCRb-APC-eF780, and CD169
+ blebs were visualized on
CCR6
+TCRcd
+ cells.
Immunofluorescence
5-mmo r7 - mm sections were prepared from paraformaldehyde-
fixed tissues, prepared as previously described [53]. In some cases,
acetone-fixed sections were stained as previously described [1].
Sections were stained with the following antibodies: Ser4-
AlexaFluor488 or Ser4-AlexaFluor647, anti-CD4-PE (clone
GK1.5), anti-IL-7Ra-PE (clone A7R34), and anti-B220-Alexa-
Fluor647 (clone RA3-6B2). Images were acquired on a Zeiss
AxioObserver Z1 or Leica TCS SP2 confocal microscope. Images
were processed using Adobe PhotoShop CS2. CD4 staining by
CD169
+ macrophages was analyzed on lymph nodes from at least
three C57BL/6 mice as well as two pairs of Cd4
–/– and control
mice. CD4 staining on CD169
+ wild-type macrophages was
similar in C57BL/6 and FvB/N mice.
CD169-deficient bone marrow chimeras
Bone marrow cells (3–6610
6) from Siglec1
–/– mice were
transferred intravenously to congenic Siglec1
+/+recipients lethally
irradiated with a split dose of 1100–1300 rads. In some
experiments, a mixture of CD45.2+ Siglec1
–/– or Siglec1
+/+ and
CD45.1+ Siglec1
+/+ bone marrow cells were transferred into
irradiated CD45.1+ recipients. Recipient mice were analyzed at
least 8 weeks later.
Two-photon microscopy
CFP
+ B cells were transferred intravenously and anti-CD169-
biotin/streptavidin-PE was injected s.c. to label SSMs in Cxcr6
gfp/+
mice 20–24 hours prior to imaging. Lymph node explants were
prepared for imaging as previously described [29,54] and imaged
with a Zeiss LSM 7MP equipped with a Chameleon laser
(Coherent). Fluorophores were excited at 870 nm and detected
with 450–490 nm (CFP), 500–550 nm (GFP) and 570–640 nm
(PE) emission filters. Images were acquired with Zen (Zeiss), and
time-lapse images generated with Imaris 7.4.0 (Bitplane). Videos
were processed with a Gaussian noise filter. Annotation and final
compilation of videos were with After Effects 7.0 software (Adobe
Systems). Video files were converted to MPEG format with AVI-
MPEG Converter for Windows 1.5 (FlyDragon Software). In some
early experiments (imaging data not shown), images were acquired
and videos generated as previously described [55].
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Figure S1 IL-7Ra
hi lymphocytes are located adjacent to
CD169+ macrophages. Three additional examples of lymph
node sections stained as in Figure 1B to detect CD169 (green) and
IL-7Ra (red). FO, follicle; T, T zone. Scale bar=50 mm.
(TIF)
Figure S2 CD169 staining on Siglec1
–/– (CD169-defi-
cient) IL-7Ra
hiCCR6
+ lymphocytes and CD11c
hi dendrit-
ic cells in mixed bone marrow chimeras. Flow cytometric
detection of CD169 staining on CD45.2
+ Siglec1
–/– or Siglec1
+/+
(red) compared to CD45.1
+ Siglec1
+/+ (blue) IL-7Ra
hiCCR6
+ cells
(A) and CD11c
hi cells (B) in mixed bone marrow chimeric mice.
Data are representative of two experiments.
(TIF)
Figure S3 IL-7Ra
hiCXCR6
hi lymphocytes at the subcap-
sular sinus and interfollicular regions. Immunofluores-
cence microscopy of lymph node sections from Cxcr6
GFP/+ mice
stained with anti-CD169 (blue) and anti-IL-7Ra (red) monoclonal
antibodies. Two examples are shown and are representative of
sections from four lymph nodes from two mice. FO, follicle; T, T
zone. Scale bar=50 mm.
(TIF)
Movie S1 Two photon imaging of CXCR6
hi cells mi-
grating in association with CD169
+ macrophages. Intra-
vital TPSLM showing CXCR6
hi cells migrate in close association
with CD169
+ macrophages (labeled with anti-CD169-PE) at the
subcapsular sinus and interfollicular regions of an explanted
Cxcr6
GFP/+ lymph node. Movie shows 12 mm maximum intensity z
projection. Time is shown as hr:min:sec. Data in Movies S1 and
S2 are representative of one experiment in which a total of five
follicles in two lymph nodes were analyzed. Similar findings were
observed in a second experiment of this type, in which
macrophages were labeled with PE-ICs as described [2]. FO,
follicle; IF, interfollicular region; SCS, subcapsular sinus.
(MPG)
Movie S2 Two photon imaging of CXCR6
hi cells mi-
grating in association with CD169
+ macrophages. Intra-
vital TPSLM showing CXCR6
hi cells migrate in close association
with CD169
+ macrophages (labeled with anti-CD169-PE) at the
subcapsular sinus and interfollicular regions of an explanted
Cxcr6
GFP/+ lymph node. The clustering of CXCR6
hi cells seen in
Movie S2 was observed in 4 of 10 movies. Movie shows 12 mm
maximum intensity z projection. Time is shown as hr:min:sec. FO,
follicle; IF, interfollicular region; SCS, subcapsular sinus.
(MPG)
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